In the postgenome era, proteomics has arisen as a promising tool for more complete
comprehension of diseases and for biomarker discovery. Some of these objectives have …

Background: Alzheimer's disease (AD) biomarkers are urgently needed for both early and
accurate diagnosis and prediction of disease progression. Past research has studied blood …

The ability to detect and diagnose Alzheimer's disease (AD) early is an ever pressing issue,
and the development of markers of disease progression that are able to distinguish AD …

Less-invasive biomarkers for early Alzheimer disease (AD) are urgently needed. The
present study aimed to establish a panel of plasma proteins that accurately distinguishes …

We have compared the brain proteome in the temporal neocortex between Alzheimer's
disease (AD) patients and non-AD individuals by using shotgun mass spectrometry based …

Abstract Parkinson's Disease (PD), a neurodegenerative disorder, is characterised by the
loss of motor function and dopamine neurons. Therapeutic avenues remain a challenge due …

The complexity of Alzheimer's disease (AD) and its long prodromal phase poses challenges
for early diagnosis and yet allows for the possibility of the development of disease modifying …

The aim of this review is to present current state of the art on the field of routine
neurochemical dementia diagnostics (NDD) with a focus on cerebrospinal fluid (CSF) …

Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease,
amyotrophic lateral sclerosis, and frontotemporal dementia have several important features …

The past decade has seen tremendous efforts in biomarker discovery and validation for
neurodegenerative diseases. The source and type of biomarkers has continued to grow for …